Phase 2 Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form to take part in the study
- You are between 45 and 80 years old (male or female)
- Your eye being studied has been diagnosed with a condition called "wet" age-related macular degeneration (nAMD)
- There is currently active abnormal blood vessel growth in the eye being studied, related to wet AMD
- The total size of the affected area in the eye being studied is within a certain limit (confirm with trial site)
- Your vision in the eye being studied falls within a specific range on a standard eye test (confirm with trial site)
Who may not be able to join:
- The eye being studied has tears, scarring, fibrosis, tissue loss, or heavy fluid buildup affecting the central part of the retina
- The eye being studied has cloudiness, a pupil that won't open properly, or other issues that block a clear view of the eye or affect vision
- The eye being studied is missing its natural lens and does not have an artificial lens, or has a specific type of lens damage (confirm with trial site)
- The eye being studied has any other eye condition or history of eye disease — apart from wet AMD — that could affect central vision or eye examination results
- The abnormal blood vessel growth in the eye being studied is caused by something other than wet AMD
- Either eye has active inflammation or infection at the time of joining the trial
- You have a known allergy to any ingredient in the study treatment, or to the dyes or medicines used during eye examinations and procedures in this study
- You have abnormal liver or kidney function
- Your blood pressure is not well controlled at the time of joining the trial
- You have had a serious heart or blood vessel event — such as a heart attack, unstable chest pain, stroke, mini-stroke (TIA), or blood clot-related condition — within the 6 months before joining
- You have another serious ongoing illness that is not well controlled
- You have taken part in another clinical trial involving a drug or medical device within the past 3 months (or longer, depending on the previous study drug)
- You are pregnant, breastfeeding, or are unable to use contraception during the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-18626789043
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment emergent adverse events(TEAE); Treatment-related treatment emergent adverse events(TRAE); Serious adverse event(SAE); Adverse event of special interest(AESI); Dose limited toxicity(DLT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.